Rheumatoid Arthritis is a common rheumatic condition that affects around 1-2% of the population and without adequate therapy results in significant disability. Recent advances in the pathogenesis of the rheumatoid arthritis have led to the dramatic development of powerful new therapeutic agents that target specific disease mechanisms. Increasing use of intensive conventional therapy and the advent of more advanced biologic agents has altered our expectations...